Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.39
(1.3%)
AUD 0.39
(1.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 601.82 Thousand AUD | -34.23% |
| 2023 | 914.97 Thousand AUD | -66.79% |
| 2022 | 2.75 Million AUD | -60.0% |
| 2021 | 6.88 Million AUD | -9.07% |
| 2020 | 7.57 Million AUD | 61.63% |
| 2019 | 4.68 Million AUD | 163.56% |
| 2018 | 1.77 Million AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | -100.0% |
| 2005 | 864.00 AUD | -99.81% |
| 2004 | 458 Thousand AUD | -50.49% |
| 2003 | 925 Thousand AUD | 150.68% |
| 2002 | 369 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 40.52 Million AUD | -1.94% |
| 1996 | 41.32 Million AUD | -37.99% |
| 1995 | 66.64 Million AUD | 48.01% |
| 1994 | 45.02 Million AUD | 36.1% |
| 1993 | 33.08 Million AUD | 23.34% |
| 1992 | 26.82 Million AUD | 5.13% |
| 1991 | 25.51 Million AUD | 21.5% |
| 1990 | 21 Million AUD | 10.53% |
| 1989 | 19 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 1.69 Million AUD | 0.0% |
| 2024 FY | 1.03 Million AUD | 13.07% |
| 2024 Q2 | 377.93 Thousand AUD | 0.0% |
| 2023 Q2 | 387.99 Thousand AUD | 0.0% |
| 2023 FY | 914.97 Thousand AUD | -66.79% |
| 2023 Q4 | 526.97 Thousand AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | 2.75 Million AUD | -60.0% |
| 2022 Q4 | 2.75 Million AUD | 0.0% |
| 2021 Q4 | -188.00 AUD | 0.0% |
| 2021 FY | 6.88 Million AUD | -9.07% |
| 2021 Q2 | 6.88 Million AUD | 0.0% |
| 2020 Q2 | 7.56 Million AUD | 0.0% |
| 2020 Q4 | 13 Thousand AUD | 0.0% |
| 2020 FY | 7.57 Million AUD | 61.63% |
| 2019 Q4 | 16.74 Thousand AUD | 0.0% |
| 2019 FY | 4.68 Million AUD | 163.56% |
| 2019 Q2 | 4.66 Million AUD | 0.0% |
| 2018 FY | 1.77 Million AUD | 0.0% |
| 2018 Q2 | 1.77 Million AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q1 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q3 | - AUD | 0.0% |
| 2008 Q2 | - AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2007 Q1 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2006 FY | - AUD | -100.0% |
| 2006 Q3 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 Q2 | - AUD | -100.0% |
| 2006 Q1 | 216.00 AUD | 0.0% |
| 2005 Q2 | 216.00 AUD | -99.81% |
| 2005 FY | 864.00 AUD | -99.81% |
| 2005 Q1 | 114.37 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 216.00 AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 Q2 | 114.37 Thousand AUD | -50.56% |
| 2004 Q1 | 231.34 Thousand AUD | 0.0% |
| 2004 FY | 458 Thousand AUD | -50.49% |
| 2004 Q3 | 114.37 Thousand AUD | 0.0% |
| 2003 FY | 925 Thousand AUD | 150.68% |
| 2003 Q3 | 231.34 Thousand AUD | 0.0% |
| 2003 Q1 | 92.34 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q2 | 231.34 Thousand AUD | 150.52% |
| 2002 Q2 | 92.34 Thousand AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 FY | 369 Thousand AUD | 0.0% |
| 2002 Q3 | 92.34 Thousand AUD | 0.0% |
| 2002 Q1 | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q1 | 10.13 Million AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 FY | 40.52 Million AUD | -1.94% |
| 1997 Q1 | 10.33 Million AUD | 0.0% |
| 1997 Q2 | 10.13 Million AUD | -1.94% |
| 1997 Q3 | 10.13 Million AUD | 0.0% |
| 1996 Q2 | 10.33 Million AUD | -37.99% |
| 1996 Q4 | 10.33 Million AUD | 0.0% |
| 1996 FY | 41.32 Million AUD | -37.99% |
| 1996 Q1 | 16.66 Million AUD | 0.0% |
| 1996 Q3 | 10.33 Million AUD | 0.0% |
| 1995 FY | 66.64 Million AUD | 48.01% |
| 1995 Q1 | 11.25 Million AUD | 0.0% |
| 1995 Q4 | 16.66 Million AUD | 0.0% |
| 1995 Q3 | 16.66 Million AUD | 0.0% |
| 1995 Q2 | 16.66 Million AUD | 48.01% |
| 1994 Q2 | 11.25 Million AUD | 36.1% |
| 1994 FY | 45.02 Million AUD | 36.1% |
| 1994 Q4 | 11.25 Million AUD | 0.0% |
| 1994 Q3 | 11.25 Million AUD | 0.0% |
| 1994 Q1 | 8.27 Million AUD | 0.0% |
| 1993 Q1 | 6.7 Million AUD | 0.0% |
| 1993 FY | 33.08 Million AUD | 23.34% |
| 1993 Q4 | 8.27 Million AUD | 0.0% |
| 1993 Q3 | 8.27 Million AUD | 0.0% |
| 1993 Q2 | 8.27 Million AUD | 23.34% |
| 1992 Q2 | 6.7 Million AUD | 5.13% |
| 1992 Q1 | 6.37 Million AUD | 0.0% |
| 1992 Q3 | 6.7 Million AUD | 0.0% |
| 1992 FY | 26.82 Million AUD | 5.13% |
| 1992 Q4 | 6.7 Million AUD | 0.0% |
| 1991 Q4 | 6.37 Million AUD | 0.0% |
| 1991 FY | 25.51 Million AUD | 21.5% |
| 1991 Q1 | 5.25 Million AUD | 0.0% |
| 1991 Q2 | 6.37 Million AUD | 21.5% |
| 1991 Q3 | 6.37 Million AUD | 0.0% |
| 1990 Q1 | 4.75 Million AUD | 0.0% |
| 1990 Q2 | 5.25 Million AUD | 10.53% |
| 1990 FY | 21 Million AUD | 10.53% |
| 1990 Q3 | 5.25 Million AUD | 0.0% |
| 1990 Q4 | 5.25 Million AUD | 0.0% |
| 1989 Q3 | 4.75 Million AUD | 0.0% |
| 1989 FY | 19 Million AUD | 0.0% |
| 1989 Q4 | 4.75 Million AUD | 0.0% |
| 1989 Q2 | 4.75 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 99.094% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -533.815% |
| Biome Australia Limited | 13 Million AUD | 95.374% |
| Patrys Limited | 1.39 Million AUD | 56.833% |
| Orthocell Limited | 5.31 Million AUD | 88.678% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | 2.4 Million AUD | 74.927% |
| PYC Therapeutics Limited | 22.05 Million AUD | 97.272% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 91.93% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 83.789% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 32.542% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 74.011% |
| CSL Limited | 22.41 Billion AUD | 99.997% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -3440.118% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -3185.044% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 99.317% |
| Starpharma Holdings Limited | 8.28 Million AUD | 92.74% |
| Nanollose Limited | 12.5 Thousand AUD | -4714.175% |
| Memphasys Limited | 60 Thousand AUD | -903.033% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 50.355% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 86.484% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 51.915% |
| Race Oncology Limited | 4 Million AUD | 84.968% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.879% |
| Dimerix Limited | 583.47 Thousand AUD | -3.144% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | 82.833% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 94.77% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 85.027% |
| BTC Health Limited | 16.36 Thousand AUD | -3578.606% |
| Acrux Limited | 5.09 Million AUD | 88.179% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 99.741% |
| Biotron Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -295.31% |
| AdAlta Limited | 1.73 Million AUD | 65.369% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -101.124% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -30.718% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -814.62% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -27.087% |
| Actinogen Medical Limited | 9.93 Million AUD | 93.94% |
| Immuron Limited | 4.9 Million AUD | 87.725% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 76.835% |